Skip to main content
OpenTrials
Completed

NCT Number: NCT01362283

Epidemiologic Study to Evaluate the Proportion of Cardiovascular Disease Risk Factors in Korean Hypertensive Patients

The purpose of this study is investigating the proportion of Cardiovascular disease risk factors of hypertensive patients.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hypertension Cardiovascular Diseases Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

About this study

Primary endpoint: To evaluate the Proportion of patients with Cardiovascular disease high risk factors

Secondary endpoint: To evaluate the Proportion of patients with Cardiovascular disease risk factors, To evaluate the Proportion of patients with Cardiovascular disease, To evaluate Target blood pressure achievement rate according to the proportion of Cardiovascular disease risks

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Essential hypertensive patient no less than 18 yeas old
  • Patient who gave informed consent form

Exclusion criteria

  • Patient was diagnosed as secondary hypertension
  • Patient who have white-coat hypertension

Treatment and study plan

Blood sampling

Other

Blood sampling for Fasting Plasma Glucose, Hemoglobin A1C, Cholesterols, Blood Urea Nitrogen, Creatinine

Other names: Blood sampling for cardiovascular disease risk

Primary outcomes

  1. Proportion of patients with cardiovascular disease high risk factors

    Time frame: 6years, average duration of hypertension

    Between patients with essential hypertension

Secondary outcomes

  1. Proportion of patients with Cardiovascular disease risk factors

    Time frame: 6years, average duration of hypertension

    Between patients with essential hypertension

  2. Proportion of patients with Cardiovascular disease

    Time frame: 6years, average duration of hypertension

    Between patients with essential hypertension

  3. Target Blood Pressure achievement rate according to the proportion of Cardiovascular disease risks

    Time frame: 6years, average duration of hypertension

    Between patients with essential hypertension

Sponsors and collaborators

Lead sponsor

GlaxoSmithKline

Industry

Registry information

Official study title

A Multi-center, Observational, Cross-sectional Study to Evaluate CVD Risk Factors in Korean Hypertensive Patients

Acronym: WONDeR

Important dates

Study start
2010
Primary completion
2011
Study completion
2011
First posted
May 30, 2011
Registry last updated
Dec 1, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.